A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 162 shares of GILD stock, worth $15,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162
Previous 161 0.62%
Holding current value
$15,219
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $66 - $83
1 Added 0.62%
162 $13,000
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $694 - $801
-11 Reduced 6.4%
161 $11,000
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $715 - $872
-10 Reduced 5.49%
172 $12,000
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $7,766 - $8,807
106 Added 139.47%
182 $14,000
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $3,253 - $3,549
44 Added 137.5%
76 $5,000
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $1,520 - $1,734
20 Added 166.67%
32 $2,000
Q1 2023

May 16, 2023

BUY
$77.31 - $88.08 $927 - $1,056
12 New
12 $0
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $22,337 - $25,158
-387 Reduced 90.63%
40 $2,000
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $1,158 - $1,451
20 Added 4.91%
427 $25,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $1,102 - $1,251
17 Added 4.36%
407 $30,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $19,827 - $22,592
350 Added 875.0%
390 $23,000
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $2,464 - $2,711
40 New
40 $3,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.